Effect of Mutation Type on Ectopic Ossification Among Adult Patients With X-Linked Hypophosphatemia
Open Access
- 22 October 2024
- journal article
- research article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 8 (12) , bvae184
Abstract
Context Causative factors for ectopic ossifications in X-linked hypophosphatemia (XLH) remain to be elucidated. Objective To investigate the genotype-phenotype correlations between PHEX and ectopic ossifications in XLH. Methods Biochemical data, spinal computed tomography scans, and X-rays of hip/knee joints were retrospectively reviewed. Genetic analysis and the measurement of plasma inorganic pyrophosphate (PPi) - a potent inhibitor of tissue calcification - were performed. The effect of PHEX mutations on protein function was predicted using nonsense-mediated decay (NMD) and 3D structure modeling. The index of ossification of the anterior/posterior longitudinal ligament and yellow ligament (OA/OP/OY index) and the sum of the OA/OP/OY index (OS index) were used to quantify the severity of spinal ligament ossification. The severity of the hip/knee osteoarthritis was evaluated by the Kellgren-Lawrence classification. Results We examined 24 distinct pathogenic PHEX variants in 28 patients from a study population of 33 individuals in 27 unrelated, non-consanguineous families. Among the 31 patients whose plasma samples were analyzed for PPi, 14 patients (45%) showed decreased plasma PPi concentrations, however, PPi concentrations did not correlate with mutation type or ectopic ossification. Fibroblast growth factor 23 levels in females with NMD-insensitive mutations trended lower than in males with NMD-sensitive mutations but failed to reach statistical significance. Both models revealed no correlations between PHEX pathogenic variant and ectopic ossification. Conclusion Neither modeling found correlates between PHEX pathogenic variants and ectopic ossificatio. The effects of PPi on ectopic ossifications in adults with XLH revealed trends that should be investigated with a large sample size.Keywords
Funding Information
- JSPS KAKENHI (JP18K09018)
- Kyowa Kirin Co Ltd.
This publication has 44 references indexed in Scilit:
- Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEXJournal of Biological Chemistry, 2003
- Structure and Function of Disease-Causing Missense Mutations in the PHEX GeneThe Journal of Clinical Endocrinology & Metabolism, 2003
- M13 endopeptidases: New conserved motifs correlated with structure, and simultaneous phylogenetic occurrence of PHEX and the bony fishProteins: Structure, Function, and Bioinformatics, 2002
- Analysis of recombinant Phex: an endopeptidase in search of a substrateAmerican Journal of Physiology-Endocrinology and Metabolism, 2001
- Mutational Analysis and Genotype-Phenotype Correlation of the PHEX Gene in X-Linked Hypophosphatemic RicketsThe Journal of Clinical Endocrinology & Metabolism, 2001
- FGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX SubstrateBiochemical and Biophysical Research Communications, 2001
- Molecular basis of renal disease. X-linked hypophosphataemia: a homologous disorder in humans and miceNephrology Dialysis Transplantation, 1999
- A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic ricketsNature Genetics, 1995
- X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometryThe American Journal of Medicine, 1991
- X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features.Radiology, 1989